Duane Morris

Duane Morris's articles

  1. Life Sciences

USPTO Signals Strong Support for Patent Eligibility in Cutting-Edge Technologies – Duane Morris Life Sciences Law

The USPTO’s new director has singled out AI, distributed ledger technologies and diagnostics as prime areas of innovation that merit patent protection. Companies, investors and other stakeholders are closely watching how the USPTO’s active guidance may better align patent practice with the ingenuity and societal benefits these technologies represent.  Read the […]
Written by
  1. Life Sciences

Aligning Capital with Compliance and IP Value – Duane Morris Life Sciences Law

By Driscoll R. Urgate, P.A. Financing and exit transactions in the life sciences industry differ fundamentally from those in traditional technology or manufacturing sectors. Scientific risk, regulatory oversight, and intellectual property rights intersect at every stage of a company’s growth, from seed capital through commercialization and acquisition. Investors and acquirers do […]
Written by
  1. Life Sciences

Vicki Norton to Speak at Personalized Cancer Vaccine Summit – Duane Morris Life Sciences Law

Duane Morris Partner Vicki G. Norton, Ph.D., will be speaking at the Personalized Cancer Vaccine Summit in Boston on Thursday, November 20. She will be on the panel “Health Economics, IP & Early Access: Navigating Legal Grey Zones in the Race to Personalized Cancer Vaccines.” The panel will discuss: How emerging […]
Written by
  1. Life Sciences

Product Liability and IP Strategies for Wearables – Duane Morris Life Sciences Law

Duane Morris will host the third session of its Wearable Webinars Series, Product Liability and IP Strategies for Wearables, on Tuesday, November 4, 2025, 12:00 p.m. to 12:30 p.m. Eastern. REGISTER About the Program As wearables continue to reshape industries—from healthcare to consumer tech—their legal implications are evolving just as rapidly. […]
Written by
  1. Life Sciences

Cybersecurity and Data Privacy Concerns for Wearables – Duane Morris Life Sciences Law

Duane Morris will host the second session of its Wearables Webinar Series, Cybersecurity and Data Privacy Concerns for Wearables, on Tuesday, October 21, 2025, from 12:00 p.m. to 12:30 p.m. Eastern. REGISTER About the Program The growing popularity of wearable devices that track consumers’ everyday health has been good for business. It […]
Written by
  1. Life Sciences

Commerce Department Singles Out Harvard for Bayh-Dole March-In Rights Enforcement – Duane Morris Life Sciences Law

There has been much concern and discussion about Commerce Secretary Howard Lutnick’s recent letter to Harvard University indicating the U.S. government’s exercise of its “march-in rights” for government-funded research resulting in IP owned by Harvard under the Bayh-Dole Act. Under the Bayh-Dole Act, recipients of U.S. government research contracts can own […]
Written by
  1. Life Sciences

Take Care When Paying Volume-Based Compensation to Sales Agents to Avoid Anti-Kickback Statute Violations – Duane Morris Life Sciences Law

By  Frederick R. Ball, Coleen W. Hill and Victoria (Tori) Hawekotte Pharmaceutical companies sometimes compensate sales agents per volume sold. The Fifth and Seventh Circuits have indicated that a company may structure such arrangements without running afoul of the Anti-Kickback Statute (AKS). However, such arrangements carry risk of violating the AKS and should […]
Written by
  1. Life Sciences

Montana Set to Become a “Wild West” Hub for Experimental Medical Treatments and Therapies – Duane Morris Life Sciences Law

By Vicki G. Norton, Ph.D., and Brandon A. Chan Ph.D. The Federal Food, Drug and Cosmetic Act generally prohibits access to investigational drugs that have not yet been approved by the United States Food and Drug Administration. Patients that have been diagnosed with a life-threatening or seriously debilitating disease may request […]
Written by
  1. Life Sciences

Federal Court Grants EPA Request to Stay Litigation Challenging 2024 Ethylene Oxide Regulation Pending Agency’s Reconsideration

By Sharon L. Caffrey, Jeffrey S. Pollack and Coleen W. Hill In June 2024, industry and environmentalist parties filed a petition in the U.S. Court of Appeals for the District of Columbia Circuit for review of a national emission standards for hazardous air pollutants regulation applicable to commercial sterilization facilities, which was […]
Written by

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.